Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia

NCT01487083 is registered in ClinicalTrials.gov with Denovo Biopharma LLC as lead sponsor.

NCT NCT01487083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01487083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Lead sponsor
Denovo Biopharma LLC
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2011
Completion date
October 31, 2012
Enrollment
129 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia